By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OvaScience 



Cambridge  Massachusetts    U.S.A.
Phone: 617-902-0682 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
OvaScience (OVAS) Announces Ravi Mehrotra, Ph.D., Joins As Chief Corporate Development Officer 5/18/2015 11:58:03 AM
OvaScience (OVAS)’s AUGMENT Fertility Treatment Continues To Demonstrate Improved Pregnancy Rates In Women With Very Poor Prognoses 5/15/2015 10:45:40 AM
OvaScience (OVAS) Reports First Quarter 2015 Financial Results 5/12/2015 11:12:00 AM
First Baby Born With OvaScience (OVAS)’s AUGMENT Fertility Treatment 5/7/2015 10:20:03 AM
OvaScience (OVAS) Welcomes John Sexton, President of New York University, To Board Of Directors 4/30/2015 12:48:53 PM
OvaScience (OVAS) Stock Egged On By Executive Faith and Strong Pipeline 4/28/2015 6:25:18 AM
Additional Clinical Reports Of OvaScience (OVAS) AUGMENT Fertility Treatment Show Improved Pregnancy Rates In Women With Multiple Prior Failed IVF Cycles 3/30/2015 4:06:51 PM
OvaScience (OVAS) AUGMENT Fertility Treatment Shows Improved Pregnancy Rates In Women With Prior Failed IVF Cycles 3/26/2015 12:12:58 PM
OvaScience (OVAS) To Host Conference Call And Webcast Presentation With IVF Specialists To Review Early AUGMENT Fertility Treatment Patient Experience 3/25/2015 10:41:51 AM
OvaScience (OVAS) Release: AUGMENT Fertility Treatment To Be Highlighted At Society For Reproductive Investigation (SRI) Annual Meeting 3/17/2015 12:00:11 PM
12345678910...
//-->